![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
Febuxostat: a new agent for lowering serum urate
Robert T Keenan1, Michael H Pillinger
1Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY 10003, USA. Robert.keenan@nyumc.org
Drugs of Today (Barcelona, Spain : 1998)
|June 6, 2009
Summary
Febuxostat effectively lowers serum urate levels in patients with chronic gout. This review covers its pharmacokinetics, efficacy, safety, and use in patients with comorbidities, highlighting its role in managing hyperuricemia.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Gout and hyperuricemia prevalence is rising globally.
- Hyperuricemia is linked to metabolic syndrome and cardiovascular disease.
- Obesity and aging exacerbate hyperuricemia, driving demand for new treatments.
Purpose of the Study:
- To review febuxostat, a novel xanthine oxidase inhibitor for chronic gout.
- To analyze its pharmacokinetics, pharmacodynamics, efficacy, and safety profile.
- To discuss its application in patients with co-existing medical conditions.
Main Methods:
- Review of phase III clinical trials for febuxostat.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Evaluation of adverse events and efficacy in diverse patient populations.
Main Results:
- Febuxostat demonstrates rapid and effective reduction of serum urate levels.
- Clinical trials supported its approval by European and US regulatory agencies.
- The drug is indicated for the chronic management of gout.
Conclusions:
- Febuxostat offers an effective therapeutic option for managing hyperuricemia and chronic gout.
- Its favorable efficacy and safety profile support its use in patients with comorbidities.
- Future implications for gout and hyperuricemia management are promising.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...